Soluble immune mediators, such as checkpoint and cytokine receptors and their ligands, are emerging as biomarkers and potential therapeutic targets in hematologic malignancies. We assessed pretreatment levels of soluble PD-L1 (sPD-L1) as a prognostic biomarker... ...

请注册登录后继续浏览